Latest News

A selection of recent news and views from Catapult Ventures follows...

Maxwellia announces funding to accelerate its mission for Self Care

Alderley Park, UK, 26 March 2018 – Maxwellia, a pioneering ‘prescription to over the counter’ medicines company, today announced that it has raised £700,000 in early-stage investment from the GM&C Life Sciences Fund, ma...

Yospace To Showcase The World’s Most Advanced Server-Side Ad Insertion Technology At NAB Show

Yospace will be demonstrating the capabilities of its server-side ad insertion platform at NAB 2018, a multi-award-winning solution that is widely regarded as the most advanced in the world. Yospace’s platform, which is fast becoming the de...

Renephra Secures Investment from Deepbridge Capital and Catapult Ventures

Manchester UK, 21st March 2018 - Renephra, a medical device company, today announced that it has raised £231,000 from Deepbridge Capital and the GM&C Life Sciences Fund, managed by Catapult Ventures. Renephra, spun out of The University...

Abzena Strengthens Specialized Bioassay Offering Through Access Agreement with Major Cell Line Depository

CAMBRIDGE, England - Abzena plc, the life sciences group providing services and technologies to enable the discovery, design, development and manufacture of biopharmaceutical products, has signed an agreement to access a major cell line depository...

Cytox awarded new Innovate UK funding for Alzheimer’s disease testing

8 March 2018: Oxford & Manchester, UK. Cytox, an emerging precision medicine leader providing genetic testing for Alzheimer’s disease, is pleased to announce that, in partnership with Cardiff University, the company has been awarded fund...

From our portfolio

Oracle Care Limited


With schools in Cheshire and Bedfordshire, Oracle Care is a provider of specialist education, the...

viewview our portfolio

Our Team

Rob Carroll

view complete team

Contact us

Binder House
7 Narborough Wood Park
Desford Road
LE19 4XT

Tel: 0116 238 8200